ArticleMedComm2022

Blockade of mIL-6R alleviated lipopolysaccharide-induced systemic inflammatory response syndrome by suppressing NF-κB-mediated Ccl2 expression and inflammasome activation.

Ji-Min Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.